Transcription of PDA Draft Technical Report No. 29 - Pharmanet
{{id}} {{{paragraph}}}
PDA Technical Report No. 29 Points to Consider forCleaning ValidationDRAFTM arch 30, Pharmaceutical cleaning validation Task ForceJames P. Agalloco, Agalloco & AssociatesWill Brame, Rhone-Poulenc RorerBohdan Ferenc, Novartis Pharmaceuticals E. Hall, , Hall & AssociatesKevin Jenkins, Pharmacia & Uphohn, T. LaMagna, Pfizer, E. Madsen, PDA (Chairman)Michael V. Mullen, , Eli Lilly and CompanyDietmar Wagenknecht, Fujisawa USA, M. Wagner, , Wyeth-Lederle Vaccines & PediatricsiiPrefaceThis document provides guidance relative to the validation of cleaning for a broad range of processingsystems and product types within the pharmaceutical industry. This effort commenced in 1991 inconjunction with individuals representing the biotechnology community. Early on it was agreed toseparate the development of cleaning validation guidance into "biotechnology" and "pharmaceutical"segments.
ii Preface This document provides guidance relative to the validation of cleaning for a broad range of processing systems and product types within the pharmaceutical industry.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Supplementary guidelines on good manufacturing, Validation Validation, Cleaning validation, Cleaning, Validation, Good manufacturing practices: validation, Appendix 7, QUALIFICATION OF TUNNEL STERILIZING MACHINE, For WHO Prequalification - Compliance Expectations, Salt spray test, PAT and Batch Recipe Execution